Sofinnova Investments’s VYNE Therapeutics VYNE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q3
Sell
-10,077
Closed -$1.26M 81
2020
Q2
$1.26M Buy
10,077
+1,677
+20% +$209K 0.08% 58
2020
Q1
$1.62M Buy
+8,400
New +$1.62M 0.15% 51